We are live on ! Find out more
AR

Advisory Research Portfolio holdings

AUM $813M
1-Year Est. Return 36.71%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$780M
AUM Growth
+$171M
Cap. Flow
+$112M
Cap. Flow %
14.34%
Top 10 Hldgs %
16.82%
Holding
517
New
169
Increased
169
Reduced
80
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$9.02M
2
AVGO icon
Broadcom
AVGO
+$6.42M
3
TSM icon
TSMC
TSM
+$6.34M
4
MDC
M.D.C. Holdings, Inc.
MDC
+$6.09M
5
OTEX icon
Open Text
OTEX
+$5.5M

Top Sells

Rank Stock Value
1
FOXA icon
Fox Class A
FOXA
+$9.87M
2
FANG icon
Diamondback Energy
FANG
+$9.52M
3
HD icon
Home Depot
HD
+$7.05M
4
MET icon
MetLife
MET
+$6.8M
5
ACN icon
Accenture
ACN
+$6.73M

Sector Composition

Rank Sector Weight
1 Technology 21.53%
2 Consumer Discretionary 17.87%
3 Industrials 15.32%
4 Healthcare 12.76%
5 Financials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IGSB icon
326
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$405K 0.05%
8,065
– –
RIO icon
327
Rio Tinto
RIO
$148B
$402K 0.05%
6,293
+1,474
+31% +$94.8K
DHI icon
328
D.R. Horton
DHI
$41B
$401K 0.05%
3,294
+1,240
+60% +$136K
ZEUS
329
DELISTED
Olympic Steel
ZEUS
$401K 0.05%
8,179
+1,042
+15% +$48.9K
BRLT icon
330
Brilliant Earth
BRLT
$18.5M
$391K 0.05%
100,782
-64,224
-39% -$244K
JHX icon
331
James Hardie Industries
JHX
$15.4B
$389K 0.05%
+14,473
New +$349K
UL icon
332
Unilever
UL
$131B
$389K 0.05%
6,631
+1,493
+29% +$88.7K
DXPE icon
333
DXP Enterprises
DXPE
$2.62B
$387K 0.05%
+10,640
New +$321K
LEN icon
334
Lennar Class A
LEN
$20.4B
$387K 0.05%
+3,190
New +$348K
BLBD icon
335
Blue Bird Corp
BLBD
$2.41B
$387K 0.05%
+17,202
New +$368K
SPOT icon
336
Spotify
SPOT
$99.2B
$386K 0.05%
2,406
-396
-14% -$57.4K
CMCSA icon
337
Comcast
CMCSA
$79.1B
$386K 0.05%
+9,287
New +$369K
GSK icon
338
GSK
GSK
$103B
$385K 0.05%
10,815
+2,418
+29% +$86.7K
VRTX icon
339
Vertex Pharmaceuticals
VRTX
$121B
$381K 0.05%
+1,084
New +$365K
DRI icon
340
Darden Restaurants
DRI
$22.5B
$381K 0.05%
2,279
+602
+36% +$94.6K
GILD icon
341
Gilead Sciences
GILD
$161B
$380K 0.05%
+4,933
New +$393K
ETN icon
342
Eaton
ETN
$157B
$378K 0.05%
+1,879
New +$330K
HCA icon
343
HCA Healthcare
HCA
$84.8B
$377K 0.05%
+1,241
New +$345K
KBR icon
344
KBR
KBR
$4.68B
$376K 0.05%
5,783
-1,471
-20% -$87.7K
PATK icon
345
Patrick Industries
PATK
$2.8B
$376K 0.05%
7,044
+292
+4% +$13.8K
SR icon
346
Spire
SR
$4.92B
$372K 0.05%
5,858
+239
+4% +$16K
BELFB
347
Bel Fuse Inc Class B
BELFB
$3.88B
$371K 0.05%
+6,461
New +$296K
FISV
348
Fiserv Inc
FISV
$27.2B
$368K 0.05%
+2,918
New +$344K
AON icon
349
Aon
AON
$77.3B
$368K 0.05%
+1,065
New +$346K
BSX icon
350
Boston Scientific
BSX
$65.8B
$365K 0.05%
+6,756
New +$353K
12 13
14
15 16

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return

Advisory Research's Q2 2023 Portfolio in Review

As of Q2 2023, Advisory Research held 517 positions worth $780M, up 28% from $608M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Advisory Research deployed $112M of net new capital in Q2 2023, opening 169 new positions and adding to 169 existing holdings. Its largest new stake was Merck: 79,479 shares worth $9.17M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Home Depot, an estimated $7.05M trimmed.

  • Advisory Research's largest Q2 2023 buy was Merck: 79,479 shares worth $9.17M.
  • Advisory Research added most to Broadcom in Q2 2023, an estimated $6.42M increase.
  • Advisory Research's biggest Q2 2023 reduction was Home Depot, cutting an estimated $7.05M.
  • Advisory Research fully exited Fox Class A in Q2 2023, selling an estimated $9.87M.
  • Advisory Research's ten largest holdings make up 17% of its $780M portfolio in Q2 2023.
  • Advisory Research opened 169 new positions and closed 81 in Q2 2023.
  • Advisory Research's portfolio value rose 28% quarter-over-quarter to $780M.

Based on Advisory Research's 13F filing for Q2 2023, filed 14 Aug 2023.